This is historically a big week for the market. In happier times November itself is generally a strong month. And while the month as a whole has been weak, these last few days have been really strong!
Improved sales during Black Friday have given the Dow and S&P a boost. On Friday the Dow closed at 11,231. Yesterday we closed a smidge over 12,000! Crazy, right?!
Hopefully you got your fill of deals on Black Friday and Cyber Monday. But if you’re still looking to buy on the cheap you might want to keep this next stock on your radar.
Industry Medical Appliances & Equipment
Recent Price $2.38
Market Cap $129.1 m
Shares Outstanding 55.2 m
Average Volume 566,300
Dividend Yield N/A
Hansen Medical (HNSN) designs, manufactures and markets cutting edge robotic tools for implanting and manipulating catheters. These are the tools and catheters used for those minimal incision operations. Their devices are designed to be safe, noninvasive and accurate.
Their flagship product is called the Sensei X System and for good reason. It sounds like the master of all catheter tools. It has 3D imaging, pinpoint controls, and tactile feedback. The technology is so sensitive it can measure pressure being applied to fragile heart tissue.
In the U.S. Hansen has a dedicated regional sales force. In Europe the company utilizes distributors as well as a regional sales force.
Hansen Medical’s third quarter numbers were released on November 7, 2011.
The company reported revenue of $5.4 million in the third quarter, up from last year’s third quarter revenue of $3.5 million. This is an increase of 54.3%. HNSN also reported a net loss of $10.1 million… an improvement year-over-year from a loss of $12.1 million.
As of September 30, 2011, the company reported $2.8 million in cash and long-term debt of $3.6 million.
KEY METRICS ANALYSIS
Trailing P/E N/A
Price / Sales 6.6 x
Return on Assets -44.3%
Insider ownership 13.5%
Short Ratio 14.6 x
Current Ratio 2.2 x
Total Debt To Equity 12 x
Hansen’s more advanced model, the Magellan, has been making the conference rounds. In November it appeared at the 38th annual VEITH symposium. The vascular surgeon’s conference is an important showroom for this new device.
Bruce Barclay, Hansen’s CEO, sang its praises in a corresponding press release. The new model has improved flexibility, distal trip control, and an added sheath. The device is already approved and available in Europe. In the U.S. the FDA is still performing a 510(k).
The 510(k) is a standard in-depth engineering analysis necessary to receive regulatory approval.
Bruce J Barclay – CEO
Arthur S. Hsieh, J.D., Ph.D. – VP of Legal Affairs
Peter J. Mariani – CFO
Michael T. MacKinnon – VP U.S. Commercial Operations
Chart Courtesy of StockCharts.com
HNSN’s 52-week low was $1.24 and the 52-week high was $5.28. Right now the stock is trading at $2.38. The 50-day moving average is near $2.72 a share and the 200-day moving average is at $3.27. The company has a market cap of $129 million and 55.2 million shares outstanding.